CLA study by researchers at the University of Colorado examined the effects of GLP-1 drugs like Ozempic and Mounjaro on the brains of 13 young women and adolescents with hormonal disorders who were using these medications. Brain scans before and after treatment showed increased connectivity in brain regions associated with attention direction. This unexpected finding has raised questions among scientists about the underlying mechanisms and potential implications. While these drugs are primarily designed to treat metabolic conditions such as obesity, overweight, and diabetes, emerging research suggests they might influence cognitive functions, including memory, executive function, and cognitive performance. Some hypotheses suggest that these drugs could affect neural activation and promote brain plasticity. However, there are also reports of negative mental effects, such as confusion and reduced emotional motivation. Researchers note that these drugs interact with hormones and receptors throughout the body, including the heart and brain, but the extent to which they reach the brain remains unclear.
Bias read (Center): The article presents findings from scientific studies without overtly favoring any particular perspective. It discusses both potential benefits and risks of GLP-1 drugs while citing multiple research sources and presenting the current state of understanding without taking a clear stance.
